Kosaki overgrowth syndrome
Kosaki overgrowth syndrome is a rare genetic disorder characterized by overgrowth, distinctive facial features, and various other abnormalities. It is named after Dr. Kenji Kosaki, who first described the syndrome.
Presentation[edit | edit source]
Individuals with Kosaki overgrowth syndrome typically exhibit macrosomia (excessive birth weight and length), macrocephaly (abnormally large head), and distinctive facial features such as a broad forehead, hypertelorism (widely spaced eyes), and a flat nasal bridge. Other common features include developmental delay, intellectual disability, and congenital heart defects.
Genetics[edit | edit source]
Kosaki overgrowth syndrome is caused by mutations in the PIK3CA gene. This gene plays a crucial role in cell growth, proliferation, and survival. Mutations in PIK3CA lead to abnormal cell growth and the various manifestations of the syndrome.
Diagnosis[edit | edit source]
Diagnosis of Kosaki overgrowth syndrome is based on clinical evaluation, identification of characteristic physical features, and genetic testing to confirm mutations in the PIK3CA gene. Prenatal diagnosis may be possible if a mutation is identified in a family member.
Management[edit | edit source]
There is no cure for Kosaki overgrowth syndrome, and treatment is symptomatic and supportive. Management may involve a multidisciplinary team including pediatricians, geneticists, cardiologists, and developmental specialists. Early intervention programs and special education services can help address developmental delays and intellectual disabilities.
Prognosis[edit | edit source]
The prognosis for individuals with Kosaki overgrowth syndrome varies depending on the severity of symptoms and associated complications. Early diagnosis and intervention can improve the quality of life for affected individuals.
See also[edit | edit source]
- Genetic disorder
- Overgrowth syndrome
- PIK3CA
- Developmental delay
- Intellectual disability
- Congenital heart defect
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD